Просмотр новости
Найдите то, что Вас интересует
Спутники
РН
SpaceX
Роскосмос
NASA
СпутникиРНSpaceXРоскосмосNASAEvidence for efficacy is based on the results from the CADENZA study
Login to your ESMO Account to sign up for ESMO newsletters and receive information about ESMO's scientific and educational resources, events, member benefits.
ESMO is a Swiss-registered not-for-profit organisation. All funding for this site is provided directly by ESMO. Via Ginevra 4, 6900 Lugano - CH
© Copyright 2026 European Society for Medical Oncology All rights reserved worldwide.
| # | Наименование новости | Тональность | Информативность | Дата публикации |
|---|---|---|---|---|
| 1 | STAT+: FDA approves Bristol multiple myeloma treatment, marking debut of novel drug class | 0 | 4.23 | 14-08-2026 |
| 2 | FDA Approves Durvalumab in Combination with BCG for High-Risk Non-Muscle Invasive Bladder Cancer | 5 | 5 | 08-07-2026 |
| 3 | FDA Approves First Freeze-Dried Plasma Product in the U.S. | 0 | 8.05 | 17-08-2026 |
| 4 | FDA accepts cemdisiran for priority review as gMG treatment | 2 | 6 | 07-07-2026 |
| 5 | ASCENIV | 0 | 10 | 19-08-2026 |
| 6 | Utebzi (tebipenem pivoxil) approved in the US for adults with complicated urinary tract infections (cUTIs) | 0 | 8.84 | 17-06-2026 |
| 7 | Sanofi’s venglustat accepted for priority review in the US to treat type 3 Gaucher disease | 0 | 16.67 | 28-05-2026 |
| 8 | FDA approves gene therapy for children with sickle cell disease ages 2+ | 5 | 7 | 09-07-2026 |
| 9 | EMA Recommends Extension of Therapeutic Indications for Sacituzumab Govitecan | 0 | 5 | 10-07-2026 |
| 10 | FDA Approves Trodelvy — A Breakthrough Treatment For One Of The Deadliest Breast Cancers | 8 | 7 | 30-06-2026 |